Group strategy

Thomas Lingelbach

President & CEO

Paris, January 29, 2019 — Valneva is a leading European biotech company specialized in innovative vaccines. Thomas Lingelbach, President & CEO of Valneva, comments on the Group’s strategy. Company website: www.valneva.com